Next Article in Journal
Novel Synthesis of Substituted 2-Trifluoromethyl and 2-Perfluoroalkyl N-Arylpyridinium Compounds—Mechanistic Insights
Next Article in Special Issue
Populations and Dynamics of Guanine Radicals in DNA strands—Direct versus Indirect Generation
Previous Article in Journal
Optimization of Light Intensity and NaNO3 Concentration in Amazon Cyanobacteria Cultivation to Produce Biodiesel
Open AccessArticle

Anomeric Spironucleosides of β-d-Glucopyranosyl Uracil as Potential Inhibitors of Glycogen Phosphorylase

1
Organic Chemistry Laboratory, Department of Chemistry, National and Kapodistrian University of Athens, 10571 Athens, Greece
2
Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece
*
Author to whom correspondence should be addressed.
Molecules 2019, 24(12), 2327; https://doi.org/10.3390/molecules24122327
Received: 13 May 2019 / Revised: 14 June 2019 / Accepted: 17 June 2019 / Published: 25 June 2019
(This article belongs to the Special Issue Biomimetic Radical Chemistry and Applications)
In the case of type 2 diabetes, inhibitors of glycogen phosphorylase (GP) may prevent unwanted glycogenolysis under high glucose conditions and thus aim at the reduction of excessive glucose production by the liver. Anomeric spironucleosides, such as hydantocidin, present a rich synthetic chemistry and important biological function (e.g., inhibition of GP). For this study, the Suárez radical methodology was successfully applied to synthesize the first example of a 1,6-dioxa-4-azaspiro[4.5]decane system, not previously constructed via a radical pathway, starting from 6-hydroxymethyl-β-d-glucopyranosyluracil. It was shown that, in the rigid pyranosyl conformation, the required [1,5]-radical translocation was a minor process. The stereochemistry of the spirocycles obtained was unequivocally determined based on the chemical shifts of key sugar protons in the 1H-NMR spectra. The two spirocycles were found to be modest inhibitors of RMGPb. View Full-Text
Keywords: type 2 diabetes; glycogen phosphorylase; anomeric spironucleosides; 1,6-dioxa-4-azaspiro[4.5]decane; [1,5]-radical translocation type 2 diabetes; glycogen phosphorylase; anomeric spironucleosides; 1,6-dioxa-4-azaspiro[4.5]decane; [1,5]-radical translocation
Show Figures

Graphical abstract

MDPI and ACS Style

Stathi, A.; Mamais, M.; Chrysina, E.D.; Gimisis, T. Anomeric Spironucleosides of β-d-Glucopyranosyl Uracil as Potential Inhibitors of Glycogen Phosphorylase. Molecules 2019, 24, 2327. https://doi.org/10.3390/molecules24122327

AMA Style

Stathi A, Mamais M, Chrysina ED, Gimisis T. Anomeric Spironucleosides of β-d-Glucopyranosyl Uracil as Potential Inhibitors of Glycogen Phosphorylase. Molecules. 2019; 24(12):2327. https://doi.org/10.3390/molecules24122327

Chicago/Turabian Style

Stathi, Aggeliki; Mamais, Michael; Chrysina, Evangelia D.; Gimisis, Thanasis. 2019. "Anomeric Spironucleosides of β-d-Glucopyranosyl Uracil as Potential Inhibitors of Glycogen Phosphorylase" Molecules 24, no. 12: 2327. https://doi.org/10.3390/molecules24122327

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop